| 21 |
Aryl hydrocarbon receptor activation leading to early life stage mortality, via increased COX-2 |
Markus Hecker |
BY-SA |
18: Activation, AhR
|
None
|
WPHA/WNT Endorsed |
1.27 |
| 23 |
Androgen receptor agonism leading to reproductive dysfunction (in repeat-spawning fish) |
Dan Villeneuve |
BY-SA |
25: Agonism, Androgen receptor
|
360: Decrease, Population growth rate
|
WPHA/WNT Endorsed |
1.12 |
| 25 |
Aromatase inhibition leading to reproductive dysfunction |
Dan Villeneuve |
BY-SA |
36: Inhibition, Aromatase
|
360: Decrease, Population growth rate
|
WPHA/WNT Endorsed |
1.12 |
| 27 |
Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11) |
Mathieu Vinken |
BY-SA |
41: Inhibition, Bile Salt Export Pump (ABCB11)
|
357: Cholestasis, Pathology
|
Under Development |
1.19 |
| 30 |
Estrogen receptor antagonism leading to reproductive dysfunction |
Dan Villeneuve |
BY-SA |
112: Antagonism, Estrogen receptor
|
360: Decrease, Population growth rate
|
Under Review |
1.12 |
| 35 |
Narcosis leading to respiratory failure |
Dries Knapen |
BY-SA |
46: Accumulation, Biological membranes
|
None
|
Under Development |
1.2 |
| 38 |
Protein Alkylation leading to Liver Fibrosis |
Brigitte Landesmann |
BY-SA |
244: Alkylation, Protein
|
344: Increase, Liver fibrosis
|
WPHA/WNT Endorsed |
1.14 |
| 39 |
Covalent Binding, Protein, leading to Increase, Allergic Respiratory Hypersensitivity Response |
Jessica Ponder |
BY-SA |
396: Covalent Binding, Protein
|
313: Increase, Allergic Respiratory Hypersensitivity Response
|
Under Development |
1.20 |
| 40 |
Covalent Protein binding leading to Skin Sensitisation |
Undefined |
BY-SA |
396: Covalent Binding, Protein
|
827: sensitisation, skin
|
WPHA/WNT Endorsed |
1.1 |
| 41 |
Sustained AhR Activation leading to Rodent Liver Tumours |
Undefined |
BY-SA |
165: Activation, Long term AHR receptor driven direct and indirect gene expression changes
|
856: Formation, Hepatocellular and Bile duct tumors
|
Under Review |
1.7 |
| 37 |
PPARα activation leading to hepatocellular adenomas and carcinomas in rodents |
Chris Corton |
BY-SA |
227: Activation, PPARα
|
719: Increase, hepatocellular adenomas and carcinomas
|
Under Development |
1.17 |
| 17 |
Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress during brain development leads to impairment of learning and memory |
Marie-Gabrielle Zurich |
BY-SA |
1487: Binding, Thiol/seleno-proteins involved in protection against oxidative stress
|
341: Impairment, Learning and memory
|
WPHA/WNT Endorsed |
1.13 |
| 18 |
PPARα activation in utero leading to impaired fertility in males |
Elise Grignard |
BY-SA |
227: Activation, PPARα
|
2 AOs
|
Under Review |
1.21 |
| 54 |
Inhibition of Na+/I- symporter (NIS) leads to learning and memory impairment |
Anna Price |
BY-SA |
424: Inhibition, Na+/I- symporter (NIS)
|
341: Impairment, Learning and memory
|
WPHA/WNT Endorsed |
1.28 |
| 106 |
Chemical binding to tubulin in oocytes leading to aneuploid offspring |
Francesco Marchetti |
BY-SA |
718: Binding, Tubulin
|
728: Increase, Aneuploid offspring
|
Under Review |
1.11 |
| 107 |
Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas in the mouse and the rat |
Kristin Lichti-Kaiser |
BY-SA |
715: Activation, Constitutive androstane receptor
|
719: Increase, hepatocellular adenomas and carcinomas
|
Under Review |
1.17 |
| 128 |
Kidney dysfunction by decreased thyroid hormone |
Jung-Hwa Oh |
BY-SA |
277: Thyroid hormone synthesis, Decreased
|
814: Occurrence, Kidney toxicity
|
Under Development |
1.40 |
| 130 |
Phospholipase A2 (LPLA2) inhibitors leading to hepatotoxicity |
Jung-Hwa Oh |
BY-SA |
828: Inhibition, Phospholipase A
|
840: Formation, Liver fibrosis
|
Under Development |
1.39 |
| 117 |
Androgen receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat) |
Charles Wood |
Open for adoption |
25: Agonism, Androgen receptor
|
719: Increase, hepatocellular adenomas and carcinomas
|
Under Development |
1.26 |
| 31 |
Oxidation of iron in hemoglobin leading to hematotoxicity |
Undefined |
Open for adoption |
213: N/A, Parent compound is converted to the reactive metabolite and forms free radicals leading to oxidation of heme iron(II) in hemoglobin to iron(III)
|
321: N/A, Cyanosis occurs
|
Under Development |
1.16 |
| 532 |
Retinoic acid receptor agonism during cerebellar development leading to impaired locomotor function |
Diana Lupu |
Open for adoption |
2201: Agonism, Retinoic acid receptor
|
2231: Locomotor function. Impaired
|
|
|
| 533 |
Retinoic acid receptor antagonism during neurodevelopment leading to impaired learning and memory |
Diana Lupu |
Open for adoption |
2232: Antagonism, Retinoic acid receptors
|
341: Impairment, Learning and memory
|
|
|
| 551 |
Increased Muscarinic M2 Receptor leading to Arrhythmia |
Young Jun Kim |
Open for adoption |
1602: Increased Muscarinic Acetylcholine Receptors
|
1106: Occurrence, cardiac arrhythmia
|
|
|
| 519 |
Cardiac ion channels blockade leading to increased incidence of cardiovascular morbidity and mortality |
Young Jun Kim |
Open for adoption |
2282: Cardiac ion channels blockade
|
1929: Increased incidence of cardiovascular morbidity and mortality in the general population
|
|
|
| 520 |
Retinoic acid receptor agonism during neurodevelopment leading to impaired learning and memory |
Diana Lupu |
Open for adoption |
2201: Agonism, Retinoic acid receptor
|
341: Impairment, Learning and memory
|
|
|